The investigators recently showed that visuomotor integration was significantly altered in schizophrenic patients during: (i) a grip force task (Teremetz et al., 2014), and (ii) a saccadic paradigm (oculomotor task)(Amado et al., 2008). Given this findings, the investigators propose a combined study of oculomotor and grip force control to better characterize the sensorimotor integration deficit. This approach may allow for identification of behavioural biomarkers of vulnerability to develop schizophrenia.
1 - Scientific background and rational Use of sensory cues is essential for execution and correction of voluntary movements. The motor areas and their regulation is of special interest in patients with schizophrenia as there is clear evidence of motor abnormalities independent of the effects of antipsychotic medication, even before the onset of the disorder. Sensorimotor abnormalities have been proposed as a valid endophenotype in schizophrenia. Our global objective is to study and provide vulnerability markers for schizophrenia. 1. Control of manual dexterity will be assessed by a force sensor (Power Grip Manipulandum, PGM) 2. Oculomotor movements during behavioral task will be recorded using a video-oculography device 3. The involvement of cortical inhibition in this volitional inhibition task will be studied by neuronavigation guided TMS coupled to EMG recording 2 - Description of the project methodology There is strong evidence for schizophrenia being a neuro-developmental disorder (Rapoport et al., 2005). It has been shown, for many years, that patients with schizophrenia exhibit abnormal patterns of sensorimotor integration (Manschreck et al., 1982), which is the capacity to integrate different sensory stimuli into appropriate motor actions. It is clinically relevant, in terms of early diagnosis and prevention, whether deficient sensorimotor integration is present in the prodromal phase of schizophrenia, and whether this constitutes a vulnerability marker for the disease. Our global objective is to study the interactions and related substratum of oculomotor movements during force control task. The secondary objectives: (i) To show that increased motor noise is indeed present in schizophrenia. (ii) To show by TMS that cortical excitability in the primary motor cortex (M1) is task-modulated and decreased in schizophrenia. (iii) Assess the role of deficient cortical inhibition in these behavioral deficits To this end, three different groups of subjects will be studied: schizophrenic patients, non-affected siblings, ultra high risk patients, non-treated schizophrenic patients and healthy control subjects.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
105
Control of manual dexterity will be assessed by a force sensor (Power Grip Manipulandum, PGM)
Oculomotor movements during behavioral task will be recorded using a video-oculography device
The involvement of cortical inhibition in this volitional inhibition task will be studied by neuronavigation guided TMS coupled to EMG recording
Centre de Recherche Clinique (CRC) - CHSA
Paris, France
RECRUITINGService Hospitalo-Universitaire (SHU) - CHSA
Paris, France
NOT_YET_RECRUITINGBehavioural assessment
Index reflecting motor performance during visuomotor task (including force and oculomotor control)
Time frame: BASELINE
Clinical scale : PANSS
Positive and Negative Syndrome Scale: Assess positive and negative symptoms
Time frame: BASELINE
Clinical scale : DIGS III
Diagnostic Interview for Genetic Studies 3.0: Overview of clinical state
Time frame: BASELINE
Clinical scale : BPRS
Brief Psychiatric Rating Scale: Assess schizophrenic symptoms
Time frame: BASELINE
Clinical scale : SAS
Simpson Angus Extra-Pyramidal Scale: Asses extra-pyramidal signs
Time frame: BASELINE
Clinical scale : AIMS
Abnormal Involuntary Movements Scale: Assess abnormal involuntary movements
Time frame: BASELINE
Clinical scale : TAP
Test battery for Attentional Performance: Assess attentional capacity (e.g. working memory)
Time frame: BASELINE
Clinical scale : Stroop
Stroop color naming test: Assess selective attention or inhibition.
Time frame: BASELINE
Clinical scale : WASI
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Wechsler Abbreviated Scale of Intelligence: Assess intelligence quotient
Time frame: BASELINE
Tracking performance (motor task): RMS Error
RMS Error (Root Mean Square)
Time frame: BASELINE
Tracking performance (motor task): Coefficient of variability
Coefficient of variability
Time frame: BASELINE
Tracking performance (motor task): Timing
Timing/inhibition
Time frame: BASELINE
Ocolomotor performance (eye tracker) : Saccade
Saccade error (back up/ catch up saccades) during smooth pursuit and fixation
Time frame: BASELINE
Ocolomotor performance (eye tracker): Gain
Gain (target velocity/gaze velocity), Reaction time
Time frame: BASELINE
Ocolomotor performance (eye tracker): Amplitude of eye movements
Amplitude (°) and velocity (°/s) of saccadic movements
Time frame: BASELINE
Motor noise
Variability of EMG response during visuomotor task
Time frame: BASELINE
Cortical excitability (MEP; TMS)
Motor evoked potential (MEP) during visuomotor task (single pulse TMS)
Time frame: BASELINE
Cortical inhibition (SICI; TMS)
Cortical inhibition measured during visuomotor task (paired-pulse TMS; MEP)
Time frame: BASELINE